CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 4 Open-market buy 10% owner bought 60,565 shares at $11.54 ($698,920)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market buy Director bought 53,613 shares at $10.64 ($570,442)
- 4 Open-market buy Director bought 10,000 shares at $11.03 ($110,300)
- 4 Open-market buy Chief Financial Officer bought 37,200 shares at $10.32 ($383,904)
- 4 Open-market buy Director bought 46,387 shares at $10.37 ($481,033)
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 4 Gift Director gave 50,000 shares (gift)
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
Page 1 of 17 · 325 filings